Clearpoint Neuro Inc (CLPT) Stock Price, Quote & News

Company Profile

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration a...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 287 9109

Website: www.clearpointneuro.com

Address:

120 S. Sierra Avenue, Suite 100, Solana Beach, United States

Thinkingman91 Nov. 16 at 3:59 PM

$CLPT I’m investing here once again. Going to rally soon. I see $29 and then it settles in at $20-21 these prices won’t be here anymore! Good luck. If you follow you know

0 · Reply

Thinkingman91 Nov. 15 at 4:05 AM

$CLPT isn’t that nifty?

1 · Reply

Thinkingman91 Nov. 15 at 4:02 AM

$CLPT I got this ticker put on StockTwits from the OTC. It’s not going down much more. It has a free run to $20. Long term it’s going to be a winner. From 2.64 -30 is nothing to scoff at. I’m a chart guy. Watch what it does

1 · Reply

Plan2TradeTrade2Plan Nov. 15 at 12:26 AM

$CLPT big sell off, Trump still in office, lots on negatives, but the chart still looks good.

0 · Reply

Twister8 Nov. 13 at 3:48 PM

$CLPT

0 · Reply

NY2CHI Nov. 12 at 2:12 PM

$CLPT ”Analysts predict that the market will grow to around $19BN by 2030, from $2.1bn in 2024, according to Majors, citing an analysis by Deloitte.” H/T to Mike on X https://eqtgroup.com/thinq/healthcare/gene-therapy-pullback-looks-like-an-opportunity-to-some-investors

0 · Reply

RichSaunder Nov. 11 at 9:49 PM

$CLPT I hope you guys haven’t covered your shorts… Going to get fun here.

0 · Reply

degeneratetrader23 Nov. 11 at 5:21 PM

$CLPT $QURE is popping.

0 · Reply

WOLFSTREET Nov. 10 at 6:06 PM

$CLPT lets focus on what matters most, S1 pegged at $24, basically what was my off ramp. Remember, 11s was on-ramp. Then you add in risk and any notices for a 360 degrees viewpoint. W/o delving into to anything else, I simply trade the CC guide. I really enjoyed this, who knows, I may even enjoy it again. I'm hopping over to $FROG where some CC action is happening.

0 · Reply

WOLFSTREET Nov. 10 at 5:58 PM

$CLPT Sucks w/o CC in your pocket. now down 40%, but there is a reason, let me explain............

0 · Reply

ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 3:55 PM EST - 4 days ago

ClearPoint Neuro: CRO Facility Should Reaccelerate Growth

Nov 6, 2025, 4:55 PM EST - 10 days ago

ClearPoint Neuro Reports Third Quarter 2025 Results

Nov 6, 2025, 4:50 PM EST - 10 days ago

ClearPoint Neuro Announces Agreement to Acquire IRRAS

Nov 5, 2025, 5:02 PM EST - 11 days ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025

Oct 7, 2025, 4:15 PM EDT - 5 weeks ago

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

Oct 6, 2025, 4:10 PM EDT - 5 weeks ago

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

Oct 2, 2025, 5:05 PM EDT - 6 weeks ago

ClearPoint Neuro: AMT-130 Highlights A Bright Future

Oct 1, 2025, 4:05 PM EDT - 6 weeks ago

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

Sep 25, 2025, 5:50 PM EDT - 7 weeks ago

ClearPoint Neuro: Selling The Tools For Brain Therapies

Sep 25, 2025, 4:05 PM EDT - 7 weeks ago

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Sep 4, 2025, 4:05 PM EDT - 2 months ago

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

Aug 14, 2025, 10:22 PM EDT - 3 months ago

ClearPoint Neuro: Biopharma Momentum Continues To Build

Aug 12, 2025, 10:31 PM EDT - 3 months ago

ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 3 months ago

ClearPoint Neuro Reports Second Quarter 2025 Results

Aug 4, 2025, 4:05 PM EDT - 3 months ago

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

Jul 23, 2025, 4:05 PM EDT - 4 months ago

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

Jun 27, 2025, 5:46 PM EDT - 5 months ago

ClearPoint Neuro: Consumables Growth Is Promising

May 20, 2025, 5:47 AM EDT - 6 months ago

I Missed The Quantum Rally - I Won't Miss The Next One

AMSC AUTL CAPR EDIT NTLA VANI VERV

May 13, 2025, 10:02 PM EDT - 6 months ago

ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:40 PM EDT - 6 months ago

ClearPoint Neuro Reports First Quarter 2025 Results

May 12, 2025, 4:05 PM EDT - 6 months ago

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

Apr 29, 2025, 12:00 AM EDT - 7 months ago

ClearPoint Neuro: Fundamentals Continue To Strengthen

Apr 28, 2025, 8:00 AM EDT - 7 months ago

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

Apr 25, 2025, 8:00 AM EDT - 7 months ago

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

Apr 24, 2025, 8:00 AM EDT - 7 months ago

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Feb 27, 2025, 11:18 PM EST - 9 months ago

ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen

Feb 26, 2025, 7:17 PM EST - 9 months ago

ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:05 PM EST - 9 months ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Feb 14, 2025, 8:00 AM EST - 9 months ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

Feb 12, 2025, 4:15 PM EST - 9 months ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

Jan 27, 2025, 4:05 PM EST - 10 months ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

Nov 13, 2024, 6:15 PM EST - 1 year ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

Nov 10, 2024, 9:35 AM EST - 1 year ago

ClearPoint Neuro: Near-Term Volatility Is No Concern

Nov 7, 2024, 10:31 PM EST - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Third Quarter 2024 Results

Oct 31, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

Oct 17, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

Aug 26, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

Aug 14, 2024, 9:33 AM EDT - 1 year ago

ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade)

Aug 8, 2024, 7:39 PM EDT - 1 year ago

ClearPoint Neuro: My Favorite Growth Stock

Aug 8, 2024, 7:25 AM EDT - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript

Jul 17, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

Jun 21, 2024, 5:11 AM EDT - 1 year ago

ClearPoint Neuro: Solid Progress Still Not Reflected In The Share Price

Jun 20, 2024, 8:45 AM EDT - 1 year ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Jun 20, 2024, 8:30 AM EDT - 1 year ago

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

Jun 1, 2024, 9:00 AM EDT - 1 year ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

May 7, 2024, 10:40 PM EDT - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q1 2024 Earnings Call Transcript

Apr 25, 2024, 2:30 AM EDT - 1 year ago

ClearPoint Neuro: Macro-Induced Multiple Compression

Thinkingman91 Nov. 16 at 3:59 PM

$CLPT I’m investing here once again. Going to rally soon. I see $29 and then it settles in at $20-21 these prices won’t be here anymore! Good luck. If you follow you know

0 · Reply

Thinkingman91 Nov. 15 at 4:05 AM

$CLPT isn’t that nifty?

1 · Reply

Thinkingman91 Nov. 15 at 4:02 AM

1 · Reply

Plan2TradeTrade2Plan Nov. 15 at 12:26 AM

$CLPT big sell off, Trump still in office, lots on negatives, but the chart still looks good.

0 · Reply

Twister8 Nov. 13 at 3:48 PM

$CLPT

0 · Reply

NY2CHI Nov. 12 at 2:12 PM

0 · Reply

RichSaunder Nov. 11 at 9:49 PM

$CLPT I hope you guys haven’t covered your shorts… Going to get fun here.

0 · Reply

degeneratetrader23 Nov. 11 at 5:21 PM

$CLPT $QURE is popping.

0 · Reply

WOLFSTREET Nov. 10 at 6:06 PM

0 · Reply

WOLFSTREET Nov. 10 at 5:58 PM

$CLPT Sucks w/o CC in your pocket. now down 40%, but there is a reason, let me explain............

0 · Reply

Investogater Nov. 10 at 4:06 PM

$CLPT In a report released today, from B. Riley Securities reiterated a Buy rating on ClearPoint Neuro, with a price target of $28.00. In addition to B. Riley Securities, ClearPoint Neuro also received a Buy from Lake Street’s Frank Takkinen in a report issued on November 7.

0 · Reply

JFDI Nov. 10 at 3:20 PM

$CLPT sittin on base, B/O retest

0 · Reply

BioGem Nov. 8 at 12:10 PM

$CLPT A short position is reasonable here: -Missed revenue by a wide margin. -Shrinking business Q-O-Q. -Net loss continues unabated without any profitability in sight. EPS missed. -Continues cash burn and now needs to take on more debt. -The acquisition consumes precious cash, and dilutes current shareholders, while it will incur higher expenses in the next several quarters. -Any future potential from their biotech partners is many years away and is extremely speculative. -Rising short interest = consensus of poor performance forward.

1 · Reply

NY2CHI Nov. 7 at 7:47 PM

$CLPT shorts could have shorted the Nasdaq to start the week and made more money than shorting this. Great work you guys! 🤡

0 · Reply

Arcides Nov. 7 at 5:31 PM

$CLPT what a week...pumped and dumped on $QURE news...

0 · Reply

NY2CHI Nov. 7 at 5:12 PM

Bought some dips today $ALAB $MELI $NVDA $IMDX and still waiting for the shorts to bring down $CLPT to hit my buy order. On a week when the Nasdaq is down 5%+, I'm surprised this is all the shorts got.

1 · Reply

d333gs Nov. 7 at 4:56 PM

$CLPT Sitting at the 200DMA ........Is there any reason for it to stay there?

0 · Reply

Twister8 Nov. 7 at 4:03 PM

$CLPT where is the bull blowhard, pumping this at 30, lol.

0 · Reply

Twister8 Nov. 7 at 3:27 PM

$CLPT shouldn't the laser revenue be off the charts? how about the drills and drill bit biz?

0 · Reply

healthcareguru Nov. 7 at 3:08 PM

$CLPT once again for suckers in the back: 😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂

0 · Reply

Twister8 Nov. 7 at 2:41 PM

$CLPT revenue topped out at 9m, Joe needed another carrot, the new widget is NOT iMRI compatible...lol.

0 · Reply

NY2CHI Nov. 7 at 2:41 PM

$CLPT got my buy order in at $14.50. Bring it down to fill it, please

0 · Reply

Market Cap	438.57M
Revenue (ttm)	31.39M
Net Income (ttm)	-18.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-60.24%
Debt to Equity Ratio	1.84

Volume	591,100
Avg Vol	1,196,608
Day's Range	N/A - N/A
Shares Out	28.42M
Stochastic %K	18%
Beta	1.28
Analysts	Strong Sell
Price Target	$29.00